Biogerontology

, Volume 13, Issue 2, pp 169–181 | Cite as

Cellular aging and senescence characteristics of human T-lymphocytes

  • Oscar Okwudiri Onyema
  • Rose Njemini
  • Ivan Bautmans
  • Wim Renmans
  • Marc De Waele
  • Tony Mets
Research Article

Abstract

CD28−, CD57+ and KLRG1+ are cell surface markers that have been used to describe senescent T-lymphocytes in humans. However, the relationship among these phenotypes during aging, and their relationship with the concept of in vitro cellular aging have not been well established. Using five-colour flow cytometry, we analyzed peripheral blood T-lymphocytes for their expression of CD28, CD57 and KLRG1 in 11 young (Y) and 11 old (O) apparently healthy human subjects. The proportions of CD28− and CD57+ cells were significantly higher among the T-cell populations of O compared to Y subjects; the proportion of KLRG1+ cells was significantly higher only among CD8+ cells. Populations that were more frequent in the elderly participants were characterised as CD28+ CD57+, CD28− CD57+ or CD28− CD57−. The expression of p16 and p21, considered as markers for in vitro senescence, was higher in CD28+ CD57+ cells than in other subpopulations in both age groups. The expression of p21 was age-related, which was not the case for p16. Thus, although both p16 and p21 are involved in T-cell senescence, they appear to behave differently. CMV infection and shifts in subpopulations are unlikely as explanations of the observed differences. Their higher levels of p16 and p21 expression, coupled with their higher prevalence in the elderly participants make CD28+ CD57+ cells the subpopulation of T-cells most closely corresponding to the concept of senescent cells.

Keywords

Cellular senescence T-lymphocytes p16 p21 CD28 CD57 KLRG1 

References

  1. Alcorta DA, Xiong Y, Phelps D, Hannon G, Beach D, Barrett JC (1996) Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci USA 93(24):13742–13747PubMedCrossRefGoogle Scholar
  2. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW, Harley CB (1992) Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 89(21):10114–10118PubMedCrossRefGoogle Scholar
  3. Almanzar G, Schwaiger S, Jenewein B, Keller M, Herndler-Brandstetter D, Wurzner R, Schonitzer D, Grubeck-Loebenstein B (2005) Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. J Virol 79(6):3675–3683PubMedCrossRefGoogle Scholar
  4. Appay V, van Lier RA, Sallusto F, Roederer M (2008) Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytom A 73(11):975–983CrossRefGoogle Scholar
  5. Ben-Porath I, Weinberg RA (2004) When cells get stressed: an integrative view of cellular senescence. J Clin Invest 113(1):8–13PubMedGoogle Scholar
  6. Beyersdorf NB, Ding X, Karp K, Hanke T (2001) Expression of inhibitory “killer cell lectin-like receptor G1” identifies unique subpopulations of effector and memory CD8 T cells. Eur J Immunol 31(12):3443–3452PubMedCrossRefGoogle Scholar
  7. Brenchley JM, Karandikar NJ, Betts MR, Ambrozak DR, Hill BJ, Crotty LE, Casazza JP, Kuruppu J, Migueles SA, Connors M, Roederer M, Douek DC, Koup RA (2003) Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 101(7):2711–2720PubMedCrossRefGoogle Scholar
  8. Brzezinska A, Magalska A, Szybinska A, Sikora E (2004) Proliferation and apoptosis of human CD8(+) CD28(+) and CD8(+) CD28(−) lymphocytes during aging. Exp Gerontol 39(4):539–544PubMedCrossRefGoogle Scholar
  9. Campisi J (2005) Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120(4):513–522PubMedCrossRefGoogle Scholar
  10. Campisi J, d’Adda di Fagagna F (2007) Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8(9):729–740PubMedCrossRefGoogle Scholar
  11. Chiu WK, Fann M, Weng NP (2006) Generation and growth of CD28nullCD8+ memory T cells mediated by IL-15 and its induced cytokines. J Immunol 177(11):7802–7810PubMedGoogle Scholar
  12. Chong LK, Aicheler RJ, Llewellyn-Lacey S, Tomasec P, Brennan P, Wang EC (2008) Proliferation and interleukin 5 production by CD8hi CD57+ T cells. Eur J Immunol 38(4):995–1000PubMedCrossRefGoogle Scholar
  13. Czesnikiewicz-Guzik M, Lee WW, Cui D, Hiruma Y, Lamar DL, Yang ZZ, Ouslander JG, Weyand CM, Goronzy JJ (2008) T cell subset-specific susceptibility to aging. Clin Immunol 127(1):107–118PubMedCrossRefGoogle Scholar
  14. Derhovanessian E, Larbi A, Pawelec G (2009) Biomarkers of human immunosenescence: impact of Cytomegalovirus infection. Curr Opin Immunol 21(4):440–445PubMedCrossRefGoogle Scholar
  15. Effros RB (2004) Replicative senescence of CD8 T cells: effect on human ageing. Exp Gerontol 39(4):517–524PubMedCrossRefGoogle Scholar
  16. Effros RB, Dagarag M, Spaulding C, Man J (2005) The role of CD8+ T-cell replicative senescence in human aging. Immunol Rev 205:147–157PubMedCrossRefGoogle Scholar
  17. Fagnoni FF, Vescovini R, Mazzola M, Bologna G, Nigro E, Lavagetto G, Franceschi C, Passeri M, Sansoni P (1996) Expansion of cytotoxic CD8+ CD28− T cells in healthy ageing people, including centenarians. Immunology 88(4):501–507PubMedCrossRefGoogle Scholar
  18. Ferguson FG, Wikby A, Maxson P, Olsson J, Johansson B (1995) Immune parameters in a longitudinal study of a very old population of Swedish people: a comparison between survivors and nonsurvivors. J Gerontol A Biol Sci Med Sci 50(6):B378–B382PubMedCrossRefGoogle Scholar
  19. Focosi D, Bestagno M, Burrone O, Petrini M (2010) CD57+ T lymphocytes and functional immune deficiency. J Leukoc Biol 87(1):107–116PubMedCrossRefGoogle Scholar
  20. Grundemann C, Bauer M, Schweier O, von Oppen N, Lassing U, Saudan P, Becker KF, Karp K, Hanke T, Bachmann MF, Pircher H (2006) Cutting edge: identification of E-cadherin as a ligand for the murine killer cell lectin-like receptor G1. J Immunol 176(3):1311–1315PubMedGoogle Scholar
  21. Hayflick L, Moorhead PS (1961) The serial cultivation of human diploid cell strains. Exp Cell Res 25:585–621CrossRefGoogle Scholar
  22. Henson SM, Franzese O, Macaulay R, Libri V, Azevedo RI, Kiani-Alikhan S, Plunkett FJ, Masters JE, Jackson S, Griffiths SJ, Pircher HP, Soares MV, Akbar AN (2009) KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8+ T cells. Blood 113(26):6619–6628PubMedCrossRefGoogle Scholar
  23. Herbig U, Jobling WA, Chen BP, Chen DJ, Sedivy JM (2004) Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol Cell 14(4):501–513PubMedCrossRefGoogle Scholar
  24. Herbig U, Ferreira M, Condel L, Carey D, Sedivy JM (2006) Cellular senescence in aging primates. Science 311(5765):1257PubMedCrossRefGoogle Scholar
  25. Ibegbu CC, Xu YX, Harris W, Maggio D, Miller JD, Kourtis AP (2005) Expression of killer cell lectin-like receptor G1 on antigen-specific human CD8+ T lymphocytes during active, latent, and resolved infection and its relation with CD57. J Immunol 174(10):6088–6094PubMedGoogle Scholar
  26. Jeyapalan JC, Ferreira M, Sedivy JM, Herbig U (2007) Accumulation of senescent cells in mitotic tissue of aging primates. Mech Ageing Dev 128(1):36–44PubMedCrossRefGoogle Scholar
  27. Koch S, Larbi A, Ozcelik D, Solana R, Gouttefangeas C, Attig S, Wikby A, Strindhall J, Franceschi C, Pawelec G (2007) Cytomegalovirus infection: a driving force in human T cell immunosenescence. Ann N Y Acad Sci 1114:23–35PubMedCrossRefGoogle Scholar
  28. Koch S, Larbi A, Derhovanessian E, Ozcelik D, Naumova E, Pawelec G (2008) Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people. Immun Ageing 5:6PubMedCrossRefGoogle Scholar
  29. Mets T, Verdonk G (1981) Variations in the stromal cell population of human bone marrow during aging. Mech Ageing Dev 15(1):41–49PubMedCrossRefGoogle Scholar
  30. Mets T, Korteweg M, Verdonk G (1979) Increased prostaglandin F2 alpha and E2 production in late passage WI38 diploid fibroblasts. Cell Biol Int Rep 3(8):691–694PubMedCrossRefGoogle Scholar
  31. Mets T, Bekaert E, Verdonk G (1983) Similarity between in vitro and in vivo cellular aging. Mech Ageing Dev 22(1):71–78PubMedCrossRefGoogle Scholar
  32. Millis AJ, Hoyle M, McCue HM, Martini H (1992) Differential expression of metalloproteinase and tissue inhibitor of metalloproteinase genes in aged human fibroblasts. Exp Cell Res 201(2):373–379PubMedCrossRefGoogle Scholar
  33. Njemini R, Demanet C, Mets T (2008) Aging-related differences in basal heat shock protein 70 levels in lymphocytes are linked to altered frequencies of lymphocyte subsets. Aging Cell 7(4):498–505PubMedCrossRefGoogle Scholar
  34. Olsson J, Wikby A, Johansson B, Lofgren S, Nilsson BO, Ferguson FG (2000) Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev 121(1–3):187–201PubMedGoogle Scholar
  35. Ouyang Q, Wagner WM, Voehringer D, Wikby A, Klatt T, Walter S, Muller CA, Pircher H, Pawelec G (2003) Age-associated accumulation of CMV-specific CD8+ T cells expressing the inhibitory killer cell lectin-like receptor G1 (KLRG1). Exp Gerontol 38(8):911–920PubMedCrossRefGoogle Scholar
  36. Pawelec G, Ferguson FG, Wikby A (2001) The SENIEUR protocol after 16 years. Mech Ageing Dev 122(2):132–134PubMedCrossRefGoogle Scholar
  37. Pawelec G, Derhovanessian E, Larbi A, Strindhall J, Wikby A (2009) Cytomegalovirus and human immunosenescence. Rev Med Virol 19(1):47–56PubMedCrossRefGoogle Scholar
  38. Petrovas C, Chaon B, Ambrozak DR, Price DA, Melenhorst JJ, Hill BJ, Geldmacher C, Casazza JP, Chattopadhyay PK, Roederer M, Douek DC, Mueller YM, Jacobson JM, Kulkarni V, Felber BK, Pavlakis GN, Katsikis PD, Koup RA (2009) Differential association of programmed death-1 and CD57 with ex vivo survival of CD8+ T cells in HIV infection. J Immunol 183(2):1120–1132PubMedCrossRefGoogle Scholar
  39. Plunkett FJ, Franzese O, Finney HM, Fletcher JM, Belaramani LL, Salmon M, Dokal I, Webster D, Lawson AD, Akbar AN (2007) The loss of telomerase activity in highly differentiated CD8+ CD28− CD27− T cells is associated with decreased Akt (Ser473) phosphorylation. J Immunol 178(12):7710–7719PubMedGoogle Scholar
  40. Rodier F, Campisi J (2011) Four faces of cellular senescence. J Cell Biol 192(4):547–556PubMedCrossRefGoogle Scholar
  41. Rudd CE, Taylor A, Schneider H (2009) CD28 and CTLA-4 coreceptor expression and signal transduction. Immunol Rev 229(1):12–26PubMedCrossRefGoogle Scholar
  42. Schirmer M, Vallejo AN, Weyand CM, Goronzy JJ (1998) Resistance to apoptosis and elevated expression of Bcl-2 in clonally expanded CD4+ CD28− T cells from rheumatoid arthritis patients. J Immunol 161(2):1018–1025PubMedGoogle Scholar
  43. Schneider EL, Mitsui Y (1976) The relationship between in vitro cellular aging and in vivo human age. Proc Natl Acad Sci USA 73(10):3584–3588PubMedCrossRefGoogle Scholar
  44. Severino J, Allen RG, Balin S, Balin A, Cristofalo VJ (2000) Is beta-galactosidase staining a marker of senescence in vitro and in vivo? Exp Cell Res 257(1):162–171PubMedCrossRefGoogle Scholar
  45. Shawi M, Autexier C (2008) Telomerase, senescence and ageing. Mech Ageing Dev 129(1–2):3–10PubMedCrossRefGoogle Scholar
  46. Smith JR, Venable S, Roberts TW, Metter EJ, Monticone R, Schneider EL (2002) Relationship between in vivo age and in vitro aging: assessment of 669 cell cultures derived from members of the Baltimore longitudinal study of aging. J Gerontol A Biol Sci Med Sci 57(6):B239–B246PubMedCrossRefGoogle Scholar
  47. Stein GH, Drullinger LF, Soulard A, Dulic V (1999) Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol Cell Biol 19(3):2109–2117PubMedGoogle Scholar
  48. Strindhall J, Nilsson BO, Lofgren S, Ernerudh J, Pawelec G, Johansson B, Wikby A (2007) No Immune Risk Profile among individuals who reach 100 years of age: findings from the Swedish NONA immune longitudinal study. Exp Gerontol 42(8):753–761PubMedCrossRefGoogle Scholar
  49. Vallejo AN, Nestel AR, Schirmer M, Weyand CM, Goronzy JJ (1998) Aging-related deficiency of CD28 expression in CD4+ T cells is associated with the loss of gene-specific nuclear factor binding activity. J Biol Chem 273(14):8119–8129PubMedCrossRefGoogle Scholar
  50. Vallejo AN, Brandes JC, Weyand CM, Goronzy JJ (1999) Modulation of CD28 expression: distinct regulatory pathways during activation and replicative senescence. J Immunol 162(11):6572–6579PubMedGoogle Scholar
  51. Vallejo AN, Schirmer M, Weyand CM, Goronzy JJ (2000) Clonality and longevity of CD4+ CD28null T cells are associated with defects in apoptotic pathways. J Immunol 165(11):6301–6307PubMedGoogle Scholar
  52. Vallejo AN, Bryl E, Klarskov K, Naylor S, Weyand CM, Goronzy JJ (2002) Molecular basis for the loss of CD28 expression in senescent T cells. J Biol Chem 277(49):46940–46949PubMedCrossRefGoogle Scholar
  53. Vasto S, Colonna-Romano G, Larbi A, Wikby A, Caruso C, Pawelec G (2007) Role of persistent CMV infection in configuring T cell immunity in the elderly. Immun Ageing 4:2PubMedCrossRefGoogle Scholar
  54. Voehringer D, Koschella M, Pircher H (2002) Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectin like receptor G1 (KLRG1). Blood 100(10):3698–3702PubMedCrossRefGoogle Scholar
  55. von Zglinicki T (2002) Oxidative stress shortens telomeres. Trends Biochem Sci 27(7):339–344CrossRefGoogle Scholar
  56. von Zglinicki T, Saretzki G, Ladhoff J, d’Adda di Fagagna F, Jackson SP (2005) Human cell senescence as a DNA damage response. Mech Ageing Dev 126(1):111–117CrossRefGoogle Scholar
  57. West MD, Pereira-Smith OM, Smith JR (1989) Replicative senescence of human skin fibroblasts correlates with a loss of regulation and overexpression of collagenase activity. Exp Cell Res 184(1):138–147PubMedCrossRefGoogle Scholar
  58. Wikby A, Maxson P, Olsson J, Johansson B, Ferguson FG (1998) Changes in CD8 and CD4 lymphocyte subsets, T cell proliferation responses and non-survival in the very old: the Swedish longitudinal OCTO-immune study. Mech Ageing Dev 102(2–3):187–198PubMedCrossRefGoogle Scholar
  59. Wikby A, Johansson B, Olsson J, Lofgren S, Nilsson BO, Ferguson F (2002) Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study. Exp Gerontol 37(2–3):445–453PubMedCrossRefGoogle Scholar
  60. Wood KL, Twigg HL 3rd, Doseff AI (2009) Dysregulation of CD8+ lymphocyte apoptosis, chronic disease, and immune regulation. Front Biosci 14:3771–3781PubMedCrossRefGoogle Scholar
  61. Yamada H, Kaibara N, Okano S, Maeda T, Shuto T, Nakashima Y, Okazaki K, Iwamoto Y (2007) Interleukin-15 selectively expands CD57+ CD28− CD4+ T cells, which are increased in active rheumatoid arthritis. Clin Immunol 124(3):328–335PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2011

Authors and Affiliations

  • Oscar Okwudiri Onyema
    • 1
  • Rose Njemini
    • 1
  • Ivan Bautmans
    • 1
  • Wim Renmans
    • 2
  • Marc De Waele
    • 2
  • Tony Mets
    • 1
    • 3
  1. 1.Gerontology Department and Frailty in Aging Research (FRIA) Group, Faculty of Medicine and PharmacyVrije Universiteit BrusselBrusselsBelgium
  2. 2.Department of HematologyUniversitair Ziekenhuis BrusselBrusselsBelgium
  3. 3.Department of Geriatrics and GerontologyUniversitair Ziekenhuis BrusselBrusselsBelgium

Personalised recommendations